Dr. Reddys Labs Q2 PAT seen up 11.1% to Rs 170.5 cr: Centrum

Net Sales are expected to increase by 2.9 percent Q-o-Q (down 16.9 percent Y-o-Y) to Rs 3316 crore, according to Centrum.
  • Language
  • App
  • Subscriptions
  • Specials
  • Sign-In
  • Register
GeStepAhead GrowMyMoney master your money IThe Winning Leap SME Special
Moneycontrol

Home » News » Earnings » Brokerage Results Estimates

Oct 19, 2016, 03.19 PM | Source: Moneycontrol.com

Dr. Reddy's Labs Q2 PAT seen up 11.1% to Rs 170.5 cr: Centrum

Net Sales are expected to increase by 2.9 percent Q-o-Q (down 16.9 percent Y-o-Y) to Rs 3316 crore, according to Centrum.

Like this story, share it with millions of investors on M3

Dr. Reddys Labs Q2 PAT seen up 11.1% to Rs 170.5 cr: Centrum

Net Sales are expected to increase by 2.9 percent Q-o-Q (down 16.9 percent Y-o-Y) to Rs 3316 crore, according to Centrum.

Post Your Comments

Share Cancel

Centrum Broking (more)

, Centrum Broking |

Centrum has come out with its second quarter (July-September) earnings estimates for the Pharmaceuticals sector. The brokerage house expects Dr. Reddy's Labs  to report net profit at Rs 170.5 crore, up 11.1 percent quarter-on-quarter.

Net Sales are expected to increase by 2.9 percent Q-o-Q (down 16.9 percent Y-o-Y) to Rs 3316 crore, according to Centrum.

Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to rise by 11.2 percent Q-o-Q (down 51.4 percent Y-o-Y) to Rs 434 crore.

Centrum's report on Dr. Reddy's Labs

We expect Dr. Reddy’s Labs (DRL) to report revenue decline of 17% YoY and revenue growth of 3% QoQ to Rs33.16bn due to higher base and absence of new launches due to three of its facilities under US FDA scanner.

Its global generic business (82% of revenues) is expected to decline by 17% YoY and grow by 3% QoQ to Rs27.35bn due to expected drop in revenues in US , Europe and emerging markets. We expect DRL’s PSAI business (14% of revenues) to decline by 20% YoY and remain flat on QoQ to Rs4.71bn.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

To read the full report click here

Buy, Hold, Sell ? Hear it first on M3
Dr. Reddys Labs Q2 PAT seen up 11.1% to Rs 170.5 cr: Centrum

See all

Get started using your favorite social network

or

Login using moneycontrol ID

Username
Password

Need help logging in? Reset password.

Don´t have an account? Sign Up

Get started using your favorite social network

or

Simply sign up using this short form

* mandatory

UserName*

Username should be atleast 4 character

Password*

Password should be 8 or more characters,
atleast 1 number, 1 symbol & 1 upper case letter

Alert

Your Password should contain
  • 8 or more characters
  • At least 1 number
  • At least 1 symbol
  • At least 1 upper case letter
Confirm Password*
Email
Already have an account? Login